An examination of biological warfare risks reveals that traditional synthetic biology tools already present extinction-level hazards, even without the intervention of artificial intelligence.
Origin Genomics founder Cathy Tie argues that editing human embryos is a moral imperative to prevent hereditary illnesses, bridging biotechnology with computation.
By combining artificial intelligence with early-stage quantum computing, resourceful researchers are bypassing traditional pharmaceutical pipelines to design novel peptide therapeutics for underserved patient populations.